Saturday, September 18, 2021
81.6 F
Fort Worth

Fort Worth-area biotech firm seeks $86M IPO

🕐 1 min read

Coppell-based ZS Pharma, a fomer TECH Fort Worth client, is looking to raise more funds with an $86 million initial public offering, the company said in a filing The biotech firm recently raised $55 million from some venture capital groups a few weeks back. ZS Pharma is developing a drug treatments for hyperkalemia called ZS-9, a potentially life-threatenening medical condition in which kidneys are unable to excrete potassium. Founded in 2008 in Indiana, ZS Pharma came to Texas to work with TECH Fort Worth and received a $2 million investment from the Texas Emerging Technology Firm. JP Morgan Chase and Credit Suisee are the managers of the offering. ZS Pharma would trade on the NASDAQ Global Market under the symbol “ZSPH”.  

Robert Francis
Robert is a Fort Worth native and longtime editor of the Fort Worth Business Press. He is a former president of the local Society of Professional Journalists and was a freelancer for a variety of newspapers, weeklies and magazines, including American Way, BrandWeek and InformatonWeek. A graduate of TCU, Robert has held a variety of writing and editing positions at publications such as the Grand Prairie Daily News and InfoWorld. He is also a musician and playwright.

Related Articles

Our Digital Sponsors

Latest Articles

Not ready to subscribe?

Try a few articles on us.

Enter your email address and we will give you access to three articles a month, to give us a try. You also get an opportunity to receive our newsletter with stories of the day.

Get our email updates

Stay up-to-date with the issues, companies and people that matter most to business in the Fort Worth.

  • Restaurants
  • Technology
  • and more!

FWBP Morning Brief

FWBP 5@5

Weekend Newsletter

  • Banking & Finance
  • Culture
  • Real Estate